119 related articles for article (PubMed ID: 36811533)
1. EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN.
Pridko O; Borikun T; Rossylna O; Rishko M; Rusyn AV
Exp Oncol; 2022 Dec; 44(4):295-299. PubMed ID: 36811533
[TBL] [Abstract][Full Text] [Related]
2. ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS.
Pridko O; Borikun T; Rossylna O; Rusyn AV
Exp Oncol; 2023 Oct; 45(2):180-186. PubMed ID: 37824774
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer.
Lukianova NY; Borikun TV; Chekhun VF
Exp Oncol; 2019 Sep; 41(3):242-247. PubMed ID: 31569928
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer.
Carvalho TM; Brasil GO; Jucoski TS; Adamoski D; de Lima RS; Spautz CC; Anselmi KF; Ozawa PMM; Cavalli IJ; Carvalho de Oliveira J; Gradia DF; Ribeiro EMSF
Front Genet; 2022; 13():865472. PubMed ID: 35846122
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ.
Lü M; Ding K; Zhang G; Yin M; Yao G; Tian H; Lian J; Liu L; Liang M; Zhu T; Sun F
Sci Rep; 2015 Mar; 5():8735. PubMed ID: 25736597
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of response to hormone therapy in breast cancer.
Rastelli F; Crispino S
Tumori; 2008; 94(3):370-83. PubMed ID: 18705406
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.
Miller TE; Ghoshal K; Ramaswamy B; Roy S; Datta J; Shapiro CL; Jacob S; Majumder S
J Biol Chem; 2008 Oct; 283(44):29897-903. PubMed ID: 18708351
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A.
Wang B; Yang Z; Wang H; Cao Z; Zhao Y; Gong C; Ma L; Wang X; Hu X; Chen S
Am J Cancer Res; 2015; 5(9):2719-29. PubMed ID: 26609479
[TBL] [Abstract][Full Text] [Related]
13. Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.
Luo Y; Wang X; Niu W; Wang H; Wen Q; Fan S; Zhao R; Li Z; Xiong W; Peng S; Zeng Z; Li X; Li G; Tan M; Zhou M
Oncol Lett; 2017 Feb; 13(2):867-874. PubMed ID: 28356971
[TBL] [Abstract][Full Text] [Related]
14. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
15. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
Li Y; Wang Y; Fan H; Zhang Z; Li N
Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
[TBL] [Abstract][Full Text] [Related]
16. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
19. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer.
Wang H; Tan G; Dong L; Cheng L; Li K; Wang Z; Luo H
PLoS One; 2012; 7(4):e34210. PubMed ID: 22523546
[TBL] [Abstract][Full Text] [Related]
20. Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.
Yu J; Wang L; Yang H; Ding D; Zhang L; Wang J; Chen Q; Zou Q; Jin Y; Liu X
J Cancer; 2016; 7(15):2317-2326. PubMed ID: 27994670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
